First National Equine Biosurveillance Program of its Kind Launched Across Canada! 

Equine Guelph’s education partner, Merck Animal Health, recently launched its national Equine Biosurveillance Pilot Program to fill an unmet need in Canada. Although there are some initiatives at provincial levels, there was currently no nationwide equine biosurveillance program in the country, until now!

In event of an outbreak of common equine respiratory diseases, this program is designed to support equine clinics with the diagnosis. It will also enable collection of information at the national level on the epidemiology of the main equine respiratory pathogens. This information can then be communicated to the horse industry to promote a better knowledge and understanding of the ever-evolving nature and dynamics of those pathogens.

‘’At Merck Animal Health, we are both very excited and proud about this new and unique initiative which will not only benefit participating clinics but the whole equine industry,” says Dr. Serge Denis DVM, Equine Consultant for Merck Animal Health. “By sharing the information collected through the program, we hope to contribute to a better knowledge and understanding of the epidemiology of the main equine respiratory diseases by the various stakeholders be it veterinarians, horse owners, barn managers or trainers.’’

In the initial phase, Merck’s Equine Biosurveillance Program will be offered to a limited number of equine clinics. Future plans include rolling it out to a significant number of practitioners.

Pathogens tested through the program:

Polymerase chain reaction (PCR) testing is available for: Equine Herpesvirus types 1 & 4, Equine Influenza Virus, Equine Rhinitis A and B Viruses, and Streptococcus equi subsp. equi.

Participating clinics are provided with a diagnostic kit containing all necessary material to collect and submit samples to the Diagnostic Service of the Faculté de Médecine Vétérinaire in St-Hyacinthe, University of Montreal.

There is no cost for participating clinics. All costs of the program are covered by Merck Animal Health. Veterinarians interested in this initiative can contact their local Merck representative.

‘’This innovative program is a powerful addition to our unique value offering and reflects Merck Animal Health’s commitment to support the Canadian equine industry through science-based products and services,’’ says Douglas Wong, Product Manager, Farm Animal Business Unit with Merck Animal Health.

Equine Guelph supports this national program as it aims to benefit overall welfare of horses in Canada. "The possibilities for developing best vaccination strategies through information gathered in this biosurveillance program are quite exciting,” says Gayle Ecker, director of Equine Guelph. "We encourage all horse owners to learn more about the importance of vaccinating by visiting our vaccination resource at EquineGuelph.ca/Tools/equiplanner.php."

Should you have any questions or concerns about the health of your horse, please speak to your equine veterinarian.  

Notes to Editor:
Equine Guelph is the horse owners' and care givers' Centre at the University of Guelph in Canada. It is a unique partnership dedicated to the health and well-being of horses, supported and overseen by equine industry groups. Equine Guelph is the epicentre for academia, industry and government - for the good of the equine industry as a whole. For further information, visit www.equineguelph.ca.

Story by: Jackie Bellamy-Zions

Photos: (graphic of Canada map with radar available upon request)

Web Link(s):

Story Link: https://www.equineguelph.ca/news/index.php?content=619

Vaccination Equi-Planner link:  https://equineguelph.ca/Tools/equiplanner.php

Media Contact:
Jackie Bellamy-Zions
Communications
Equine Guelph
Guelph, ON  N1G 2W1
519.824.4120 ext. 54756
jbellamy@uoguelph.ca

AHP has not verified the factual statements in any message and AHP assumes no responsibility for the contents of, or any damage resulting from, any communication in the Newsgroup. Publication in the Newsgroup is not an endorsement by the organization of any product, person, or policy.